David L Suter is an accomplished inventor based in Rochester Hills, MI (US). He has made significant contributions to the field of medical treatments, particularly in addressing peripheral vascular disease. With a total of 2 patents, Suter's work focuses on innovative methods that utilize protein solutions for effective treatment.

Latest Patents

Suter's latest patents revolve around the treatment of peripheral vascular disease using protein solutions. These methods involve administering a protein solution at the site of a defect, incorporating at least two proteins from a specific group that includes IL-1ra, sTNF-RI, sTNF-RII, IGF-I, EGF, HGF, PDGF-AB, PDGF-BB, VEGF, TGF-β1, and sIL-1RII. Additionally, the solution may comprise white blood cells, platelets, concentrated bone marrow aspirate, and various combinations thereof. This innovative approach aims to enhance the healing process and improve patient outcomes.

Career Highlights

David L Suter is currently associated with Biomet Biologics, LLC, where he continues to develop and refine his groundbreaking treatments. His expertise in the field has positioned him as a key player in advancing medical technologies that address critical health issues.

Collaborations

Suter collaborates with talented professionals in his field, including Matthew D Landrigan and Jennifer E Woodell-May. These partnerships foster an environment of innovation and creativity, leading to the development of effective medical solutions.

Conclusion

David L Suter's contributions to the treatment of peripheral vascular disease through innovative protein solutions highlight his dedication to improving healthcare. His work not only showcases his inventive spirit but also emphasizes the importance of collaboration in advancing medical science.